Back to Search
Start Over
Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer : Alexandra Leary.
- Source :
-
BMC cancer [BMC Cancer] 2024 Jul 29; Vol. 24 (1), pp. 911. Date of Electronic Publication: 2024 Jul 29. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1471-2407
- Volume :
- 24
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BMC cancer
- Accession number :
- 39075404
- Full Text :
- https://doi.org/10.1186/s12885-024-12700-0